Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 4
2009 1
2010 2
2016 2
2017 4
2018 2
2019 1
2020 13
2021 7
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D. Smolen JS, et al. Among authors: kerschbaumer a. Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655. Epub 2020 Jan 22. Ann Rheum Dis. 2020. PMID: 31969328 Free article.
Fever of unknown origin (FUO) revised.
Unger M, Karanikas G, Kerschbaumer A, Winkler S, Aletaha D. Unger M, et al. Among authors: kerschbaumer a. Wien Klin Wochenschr. 2016 Nov;128(21-22):796-801. doi: 10.1007/s00508-016-1083-9. Epub 2016 Sep 26. Wien Klin Wochenschr. 2016. PMID: 27670857 Free PMC article. Review.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Nash P, Kerschbaumer A, Dörner T, Dougados M, Fleischmann RM, Geissler K, McInnes I, Pope JE, van der Heijde D, Stoffer-Marx M, Takeuchi T, Trauner M, Winthrop KL, de Wit M, Aletaha D, Baraliakos X, Boehncke WH, Emery P, Isaacs JD, Kremer J, Lee EB, Maksymowych WP, Voshaar M, Tam LS, Tanaka Y, van den Bosch F, Westhovens R, Xavier R, Smolen JS. Nash P, et al. Among authors: kerschbaumer a. Ann Rheum Dis. 2021 Jan;80(1):71-87. doi: 10.1136/annrheumdis-2020-218398. Epub 2020 Nov 6. Ann Rheum Dis. 2021. PMID: 33158881 Free PMC article.
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M, Primdahl J, McGonagle DG, Aletaha D, Balanescu A, Balint PV, Bertheussen H, Boehncke WH, Burmester GR, Canete JD, Damjanov NS, Kragstrup TW, Kvien TK, Landewé RBM, Lories RJU, Marzo-Ortega H, Poddubnyy D, Rodrigues Manica SA, Schett G, Veale DJ, Van den Bosch FE, van der Heijde D, Smolen JS. Gossec L, et al. Among authors: kerschbaumer a. Ann Rheum Dis. 2020 Jun;79(6):700-712. doi: 10.1136/annrheumdis-2020-217159. Ann Rheum Dis. 2020. PMID: 32434812 Free PMC article.
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JWJ, Burmester GR, de Wit M, Falzon L, Landewé R. Kerschbaumer A, et al. Ann Rheum Dis. 2020 Jun;79(6):744-759. doi: 10.1136/annrheumdis-2019-216656. Epub 2020 Feb 7. Ann Rheum Dis. 2020. PMID: 32033937 Free PMC article.
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.
Sepriano A, Kerschbaumer A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JW, Burmester GR, de Wit M, Falzon L, Landewé R. Sepriano A, et al. Among authors: kerschbaumer a. Ann Rheum Dis. 2020 Jun;79(6):760-770. doi: 10.1136/annrheumdis-2019-216653. Epub 2020 Feb 7. Ann Rheum Dis. 2020. PMID: 32033941
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research.
Kerschbaumer A, Smolen JS, Nash P, Doerner T, Dougados M, Fleischmann R, Geissler K, McInnes IB, Takeuchi T, Trauner M, Winthrop K, de Wit M, Boehncke WH, Falzon L, van der Heijde D. Kerschbaumer A, et al. RMD Open. 2020 Nov;6(3):e001374. doi: 10.1136/rmdopen-2020-001374. RMD Open. 2020. PMID: 33188136 Free PMC article.
[Rheumatoid arthritis].
Aletaha D, Kerschbaumer A. Aletaha D, et al. Among authors: kerschbaumer a. Z Rheumatol. 2017 Feb;76(1):8-14. doi: 10.1007/s00393-016-0251-7. Z Rheumatol. 2017. PMID: 28058499 Free article. Review. German.
Disease activity assessment in patients with psoriatic arthritis.
Kerschbaumer A, Smolen JS, Aletaha D. Kerschbaumer A, et al. Best Pract Res Clin Rheumatol. 2018 Jun;32(3):401-414. doi: 10.1016/j.berh.2018.08.004. Epub 2018 Oct 11. Best Pract Res Clin Rheumatol. 2018. PMID: 31171311 Review.
36 results